|Series B, 9/12 |
SV Life Sciences
New Leaf Venture Partners
International Biotechnology Trust
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.